Benlysta 200 MG/ML autoinjectml
Ended Awarded
- Contract number
- SPE2DB25FUQKQ
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $6,165
Award facts
- Contract value 100% obligated
- $6,165.34 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Benlysta 200 mg/ml auto-injectors, with a ceiling value of $6,165.34 and an ultimate completion date of October 6, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Benlysta is a biologic immunosuppressant used primarily in the treatment of systemic lupus erythematosus and lupus nephritis, representing a specialized pharmaceutical product within the company's broader federal medical supply portfolio.
This delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026. The IDC enables AmerisourceBergen to serve as a prime vendor for pharmaceutical products and medical supplies across multiple therapeutic domains to support military healthcare programs, the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems worldwide. As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen has demonstrated the capability to fulfill both specialized biologics and routine pharmaceutical supply requirements through competitive federal contracting.
Quick answers
Who was awarded contract SPE2DB25FUQKQ?
SPE2DB25FUQKQ was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 15, 2025.
How much is contract SPE2DB25FUQKQ worth?
The government has obligated $6,165 on SPE2DB25FUQKQ.
Is contract SPE2DB25FUQKQ an order under another contract?
Yes. SPE2DB25FUQKQ is a delivery order under SPE2DB25D3404, an indefinite delivery contract.
Was contract SPE2DB25FUQKQ competed?
The extent of competition for SPE2DB25FUQKQ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award